# Intra-peritoneal Chemotherapy in Ovarian Cancer

> **NCT02861872** · — · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Ovarian Neoplasms
- Immune Tolerance
- Neoplasms
- Effects of Chemotherapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02861872
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2016-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02861872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02861872, "Intra-peritoneal Chemotherapy in Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02861872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
